We are live on ! Find out more
GF

Gabelli Funds Portfolio holdings

AUM $14.8B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+32.24%
3 Year Est. Return
+88.06%
5 Year Est. Return
+130.29%
10 Year Est. Return
+486.58%
AUM
$14.1B
AUM Growth
+$963M
Cap. Flow
-$36.3M
Cap. Flow %
-0.26%
Top 10 Hldgs %
12.86%
Holding
1,287
New
192
Increased
280
Reduced
411
Closed
65

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$28.6M
2
BPMC
Blueprint Medicines
BPMC
+$21.9M
3
SKX
Skechers
SKX
+$16.9M
4
FARO
Faro Technologies
FARO
+$14M
5
DNB
Dun & Bradstreet
DNB
+$13M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$43M
2
BECN
Beacon Roofing Supply, Inc.
BECN
+$20.6M
3
DFS
Discover Financial Services
DFS
+$18M
4
FNA
Paragon 28, Inc.
FNA
+$16.8M
5
NEM icon
Newmont
NEM
+$16.2M

Sector Composition

Rank Sector Weight
1 Industrials 20.94%
2 Financials 12.8%
3 Communication Services 10.31%
4 Technology 10.08%
5 Utilities 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HSY icon
626
Hershey
HSY
$36.6B
$2.82M 0.02%
17,000
+4,000
+31% +$659K
BSET icon
627
Bassett Furniture
BSET
$170M
$2.81M 0.02%
184,800
-200
-0.1% -$3.31K
QCOM icon
628
Qualcomm
QCOM
$177B
$2.78M 0.02%
17,430
– –
ALNT icon
629
Allient
ALNT
$1.45B
$2.78M 0.02%
76,435
-1,134
-1% -$31.5K
PPBI
630
DELISTED
Pacific Premier Bancorp
PPBI
$2.76M 0.02%
+130,737
New +$2.72M
CTLP
631
DELISTED
Cantaloupe
CTLP
$2.75M 0.02%
+250,384
New +$2.17M
MLM icon
632
Martin Marietta Materials
MLM
$34.3B
$2.74M 0.02%
5,000
– –
NAGE
633
Niagen Bioscience
NAGE
$257M
$2.74M 0.02%
189,900
-14,900
-7% -$147K
DELL icon
634
Dell
DELL
$270B
$2.73M 0.02%
22,300
+1,000
+5% +$102K
NTR icon
635
Nutrien
NTR
$32.5B
$2.7M 0.02%
46,400
-6,190
-12% -$350K
MU icon
636
Micron Technology
MU
$998B
$2.69M 0.02%
21,800
+300
+1% +$28K
WHD icon
637
Cactus
WHD
$3.77B
$2.68M 0.02%
+61,377
New +$2.56M
TME icon
638
Tencent Music
TME
$15.3B
$2.65M 0.02%
136,000
-6,000
-4% -$94.3K
WWW icon
639
Wolverine World Wide
WWW
$1.58B
$2.64M 0.02%
146,000
– –
LIN icon
640
Linde
LIN
$235B
$2.64M 0.02%
5,625
+175
+3% +$79.9K
GNTX icon
641
Gentex
GNTX
$4.84B
$2.64M 0.02%
120,000
– –
SHOE
642
Shoe Station Group
SHOE
$407M
$2.62M 0.02%
+139,777
New +$2.66M
ACH
643
Accendra Health
ACH
$247M
$2.6M 0.02%
286,000
-40,000
-12% -$295K
RRX icon
644
Regal Rexnord
RRX
$13.8B
$2.59M 0.02%
17,885
+11,197
+167% +$1.4M
IMAX icon
645
IMAX
IMAX
$2.48B
$2.59M 0.02%
92,482
+70,482
+320% +$1.83M
NTCT icon
646
NETSCOUT
NTCT
$2.85B
$2.57M 0.02%
+103,728
New +$2.31M
JJSF icon
647
J&J Snack Foods
JJSF
$1.46B
$2.55M 0.02%
22,500
-300
-1% -$36.5K
OCSL icon
648
Oaktree Specialty Lending
OCSL
$1.04B
$2.55M 0.02%
186,379
+5,467
+3% +$77.1K
MAG
649
DELISTED
MAG Silver
MAG
$2.54M 0.02%
120,000
-219,000
-65% -$3.89M
TRST
650
Trustco Bank Corp NY
TRST
$981M
$2.53M 0.02%
75,730
+425
+0.6% +$13.1K
24 25
26
27 28

Similar funds

FCAS
First Command Advisory Services Fort Worth, Texas $14.8B AUM 18.11% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
CCM
Cantillon Capital Management New York $15.1B AUM 23.54% 1-Year Est. Return
AT
AMF Tjänstepension Stockholm, Sweden $15.1B AUM 30.1% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $15.1B AUM 26.53% 1-Year Est. Return

Gabelli Funds's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli Funds held 1,287 positions worth $14.1B, up 7.3% from $13.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Gabelli Funds's Q2 2025 filing shows 192 new, 280 increased, 411 reduced and 65 closed positions. Its largest new stake was Blueprint Medicines: 211,169 shares worth $27.1M. The largest sale was Intra-Cellular Therapies Inc., an estimated $43M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.

  • Gabelli Funds's largest Q2 2025 buy was Blueprint Medicines: 211,169 shares worth $27.1M.
  • Gabelli Funds added most to SpringWorks Therapeutics in Q2 2025, an estimated $28.6M increase.
  • Gabelli Funds's biggest Q2 2025 reduction was Newmont, cutting an estimated $16.2M.
  • Gabelli Funds fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $43M.
  • Gabelli Funds's ten largest holdings make up 13% of its $14.1B portfolio in Q2 2025.
  • Gabelli Funds opened 192 new positions and closed 65 in Q2 2025.
  • Gabelli Funds's portfolio value rose 7.3% quarter-over-quarter to $14.1B.

Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.